CorVel Corporation Cash Flow Statement
CRVL / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
N/A
FY2025
Free Cash Flow
N/A
FY2025
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | $95.2M | $76.3M | $66.4M | $66.4M | $46.4M | $47.4M | $46.7M | $35.7M | $29.5M | $28.5M | $28.6M | $34.4M | $26.7M | $26.6M |
| Depreciation & Amortization | - | $29.5M | $26.3M | $25.1M | $23.9M | $23.4M | $22.5M | $23.0M | $21.8M | $20.9M | $20.0M | $18.0M | $16.4M | $15.7M | $14.7M |
| Operating Cash Flow | - | $127.3M | $99.2M | $82.3M | $67.2M | $94.4M | $80.8M | $78.6M | $62.2M | $52.1M | $51.3M | $44.3M | $54.8M | $54.8M | $35.7M |
| Capital Expenditures | - | $35.8M | $29.2M | $26.3M | $29.8M | $17.2M | $32.4M | $15.3M | $27.7M | $31.0M | $16.8M | $22.9M | $18.3M | $14.9M | $23.2M |
| Free Cash Flow | - | $91.6M | $70.0M | $56.0M | $37.4M | $77.1M | $48.5M | $63.4M | $34.5M | $21.0M | $34.6M | $21.4M | $36.5M | $39.9M | $12.5M |
| Share Buybacks | - | $37.6M | $45.7M | $93.7M | $90.1M | $32.7M | $65.6M | $35.2M | $11.2M | $28.0M | $31.5M | $31.8M | $27.2M | $30.7M | $21.6M |
| FCF Margin | - | 10.2% | 8.8% | 7.8% | 5.8% | 14.0% | 8.2% | 10.6% | 6.2% | 4.0% | 6.9% | 4.3% | 7.6% | 9.3% | 3.0% |